journal article·2025-02-26

Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform

Lian-Hua Fu, Mengting Yin, Xin Chen, Chen Yang, Jing Lin, Xiansong Wang, Baoguo Jiang, Peng Huang

Nano Letters· Volume 25· Issue 8
Publisher page

Abstract

Diabetic osteoporosis (DOP) is a chronic complication of diabetes mellitus (DM) that impairs bone health, and effective management of DOP remains a formidable challenge. In this study, we developed a biocatalytic cascade nanoplatform, GOx@SrCaP-CAT-Tet, offering osteogenic, angiogenic, and anti-inflammatory activities for targeted DOP management. The platform includes glucose oxidase (GOx) and catalase (CAT), encapsulated in strontium-doped calcium phosphate (SrCaP), converting glucose into gluconic acid and hydrogen peroxide (H 2 O 2 ), alleviating the hyperglycemia and promoting hypoxia-induced vascularization. Both the generated H 2 O 2 and any overabundance of H 2 O 2 in the DOP microenvironment can be scavenged by CAT, thus relieving inflammation. Via a surface modified with tetracycline (Tet) for bone targeting, the release of Sr 2+, Ca 2+, and PO 4 3– can stimulate osteogenesis and suppress osteoclastogenesis, thereby hastening bone formation and reversing osteoporosis. This nanoplatform shows promise in managing DOP both in vitro and in vivo . Our findings open a new horizon for managing DOP through biocatalytic cascade reactions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School

Shenzhen University

Department of Plastic and Reconstructive Surgery, Shanghai Key Laboratory of Tissue Engineering, Shanghai Ninth People’s Hospital

Shanghai Jiao Tong University School of Medicine

Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute

University of Chinese Academy of Sciences

The Third Affiliated Hospital of Xinxiang Medical University, Clinical Medical Center of Tissue Engineering and Regeneration

Xinxiang Medical University

National Center for Trauma Medicine, Key Laboratory of Trauma and Neural Regeneration, Ministry of Education, Department of Orthopedics and Trauma

Peking University People’s Hospital

Shenzhen University General Hospital, Shenzhen University Medical School

Funding

National Key Research and Development Program of China · Science and Technology Planning Project of Shenzen Municipality · National Natural Science Foundation of China · Shenzhen University · Shenzhen Medical Research Fund

References (54)

Show source-provided references
1. 10.1016/j.phanu.2021.10028010.1016/j.phanu.2021.100280 ↗
2. 10.1016/j.diabres.2021.10911910.1016/j.diabres.2021.109119 ↗
3. 10.1038/nrendo.2011.23310.1038/nrendo.2011.233 ↗
4. 10.1016/j.arr.2024.10220110.1016/j.arr.2024.102201 ↗
5. 10.1038/s41413-024-00319-710.1038/s41413-024-00319-7 ↗
6. 10.3390/biomedicines1009219110.3390/biomedicines10092191 ↗
7. 10.1210/jc.2017-0004210.1210/jc.2017-00042 ↗
8. 10.1038/s41413-022-00198-w10.1038/s41413-022-00198-w ↗
9. 10.1016/j.engreg.2022.09.00410.1016/j.engreg.2022.09.004 ↗
10. 10.1038/nrendo.2016.15310.1038/nrendo.2016.153 ↗
11. 10.1016/j.ejphar.2019.17280510.1016/j.ejphar.2019.172805 ↗
12. 10.1016/j.biopha.2018.08.13110.1016/j.biopha.2018.08.131 ↗
13. 10.1186/s12902-022-01103-610.1186/s12902-022-01103-6 ↗
14. 10.1016/j.nantod.2024.10216610.1016/j.nantod.2024.102166 ↗
15. 10.3390/ijms2115530310.3390/ijms21155303 ↗
16. 10.1039/C7CS00891K10.1039/C7CS00891K ↗
17. 10.1002/adma.20180832510.1002/adma.201808325 ↗
18. 10.1038/s41467-022-29082-110.1038/s41467-022-29082-1 ↗
19. 10.1002/adma.20210398010.1002/adma.202103980 ↗
20. 10.1016/j.actbio.2023.03.01710.1016/j.actbio.2023.03.017 ↗
21. 10.1002/adma.20200689210.1002/adma.202006892 ↗
22. 10.1002/adfm.20231385310.1002/adfm.202313853 ↗
23. 10.1002/adfm.20190549310.1002/adfm.201905493 ↗
24. 10.1021/acsnano.2c0456610.1021/acsnano.2c04566 ↗
25. 10.1016/j.actbio.2022.12.00110.1016/j.actbio.2022.12.001 ↗
26. 10.1002/adma.20230527710.1002/adma.202305277 ↗
27. 10.1002/adfm.20210137210.1002/adfm.202101372 ↗
28. 10.1038/nrd280310.1038/nrd2803 ↗
29. 10.1016/j.redox.2016.12.01110.1016/j.redox.2016.12.011 ↗
30. 10.1002/adfm.20200984810.1002/adfm.202009848 ↗
31. 10.1002/anie.20220458410.1002/anie.202204584 ↗
32. 10.1016/j.biomaterials.2021.12111710.1016/j.biomaterials.2021.121117 ↗
33. 10.1016/j.biomaterials.2021.12089510.1016/j.biomaterials.2021.120895 ↗
34. 10.7150/thno.9308810.7150/thno.93088 ↗
35. 10.1038/s41413-022-00224-x10.1038/s41413-022-00224-x ↗
36. 10.1016/j.mtbio.2023.10063610.1016/j.mtbio.2023.100636 ↗
37. 10.3390/biom1306100610.3390/biom13061006 ↗
38. 10.1021/acs.nanolett.2c0407810.1021/acs.nanolett.2c04078 ↗
39. 10.1186/s40824-023-00474-810.1186/s40824-023-00474-8 ↗
40. 10.3390/ma1505172410.3390/ma15051724 ↗
41. 10.1039/C8CS00489G10.1039/C8CS00489G ↗
42. 10.1021/cr800427g10.1021/cr800427g ↗
43. 10.1002/adma.20140335410.1002/adma.201403354 ↗
44. 10.1016/j.bioactmat.2020.09.02410.1016/j.bioactmat.2020.09.024 ↗
45. 10.7150/thno.4010310.7150/thno.40103 ↗
46. 10.7150/thno.3730110.7150/thno.37301 ↗
47. 10.1038/nnano.2016.7210.1038/nnano.2016.72 ↗
48. 10.1002/adma.20231165910.1002/adma.202311659 ↗
49. 10.1002/adhm.20210156310.1002/adhm.202101563 ↗
50. 10.1021/acsnano.9b0583610.1021/acsnano.9b05836 ↗
51. 10.1021/jacs.0c0730910.1021/jacs.0c07309 ↗
52. 10.1002/med.2175910.1002/med.21759 ↗
53. 10.1016/j.nantod.2023.10183810.1016/j.nantod.2023.101838 ↗
54. 10.1039/D2CY01641A10.1039/D2CY01641A ↗